86.21.Z - General medical practice activities
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
64.99.Z - Other financial service activities, except insurance and pension funding not elsewhere classified
72.19.Z - Other research and experimental development on natural sciences and engineering
77.39.Z - Rental and leasing of other machinery, equipment and tangible goods not elsewhere classified
82.99.Z - Other business support service activities not elsewhere classified
86.22.Z - Specialist medical practice activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0 | -0 | -0 | 8,8 |
Gross profit (loss) | 0,9 | 1,1 | 0,6 | -42,2 |
EBITDA | -0 | -0 | -0 | 8,8 |
Short time liabilities | 0 | 0 | 0 | 6,8 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | 3 | 3,2 | 3,3 | 3,6 |
Operating profit (EBIT) | -0 | -0 | -0 | 8,8 |
Assets | 6,2 | 6 | 5,7 | -5,1 |
Net profit (loss) | 0,9 | 1,1 | 0,6 | -42,2 |
Cash | 0,5 | 0,4 | 0,1 | -82,3 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 3,2 | 2,9 | 2,4 | -14,7 |
Working assets | 0,5 | 0,4 | 0,1 | -82,3 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 30,9 | 34,4 | 19,2 | -15,2 |
Equity capital to total assets | 48 | 52,5 | 57,4 | 4,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 640.2813720703125 | 304.0799865722656 | 50.40896987915039 | -253,7 |
Net dept to EBITDA | -191.4125518798828 | -627.7990112304688 | -656.9288940429688 | -29,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane